COVID-19 Spike Protein Linked to Increased Lung Cancer Risk Through Inflammatory Pathway
New study suggests SARS-CoV-2 may slightly increase lung cancer risk by triggering a biological chain reaction driven by the virus's spike protein that promotes inflammation and tumor development.
·1 source
